BR100 Increased By (0.02%)
BR30 Decreased By (-0.25%)
KSE100 Increased By (0.03%)
KSE30 Increased By (0.02%)
AGHA 6.74 Increased By ▲ 0.06 (0.9%)
BECO 4.38 Increased By ▲ 0.01 (0.23%)
BML 56.95 Decreased By ▼ -0.37 (-0.65%)
BOP 30.35 No Change ▼ 0.00 (0%)
CNERGY 13.08 Decreased By ▼ -0.04 (-0.3%)
CSIL 5.38 Decreased By ▼ -0.03 (-0.55%)
FCCL 52.76 Decreased By ▼ -0.03 (-0.06%)
FFL 14.65 Decreased By ▼ -0.07 (-0.48%)
FNEL 1.13 Increased By ▲ 0.01 (0.89%)
KEL 6.18 Increased By ▲ 0.09 (1.48%)
KOSM 6.08 Increased By ▲ 0.35 (6.11%)
LOTCHEM 26.52 Increased By ▲ 0.06 (0.23%)
MLCF 93.20 Increased By ▲ 0.04 (0.04%)
NBP 165.00 Increased By ▲ 0.34 (0.21%)
NCPL 55.55 Decreased By ▼ -0.11 (-0.2%)
NPL 60.75 Decreased By ▼ -0.41 (-0.67%)
OGDC 315.44 Decreased By ▼ -1.29 (-0.41%)
PACE 9.95 Increased By ▲ 0.08 (0.81%)
PAEL 35.55 Decreased By ▼ -0.08 (-0.22%)
PIBTL 14.80 Increased By ▲ 0.12 (0.82%)
PPL 224.40 Decreased By ▼ -2.51 (-1.11%)
PRL 92.40 Decreased By ▼ -0.62 (-0.67%)
PTC 60.35 Increased By ▲ 0.09 (0.15%)
SSGC 23.85 Increased By ▲ 0.04 (0.17%)
TBL 8.76 Increased By ▲ 0.01 (0.11%)
TELE 7.80 No Change ▼ 0.00 (0%)
TPL 22.44 Increased By ▲ 0.09 (0.4%)
TPLP 12.89 Decreased By ▼ -0.08 (-0.62%)
TREET 22.18 Increased By ▲ 0.02 (0.09%)
TRG 56.52 Decreased By ▼ -0.04 (-0.07%)
Business & Finance

EU preparing orders for 1.8bn vaccine booster shots

  • The planned orders will be for so-called mRNA vaccines, with a preference for manufacturers who are EU-based or who have production facilities in Europe.
  • Only the Biontech/Pfizer vaccine, which is manufactured in Belgium and Germany, and Moderna, which manufactures in Spain and Switzerland, currently meet these requirements.
Published Updated
By

BERLIN: The European Union will shortly sign contracts to purchase up to 1.8 billion doses of coronavirus vaccine to cover the bloc's need for booster shots over the coming two years, German daily Die Welt reported on Friday.

The newspaper said that contracts would be signed for deliveries of 900 million doses, with further contracts creating an option for another 900 million doses to be bought. The planned purchases would also cover the 70-80 million children in the EU, who are not currently being vaccinated.

The planned orders will be for so-called mRNA vaccines, with a preference for manufacturers who are EU-based or who have production facilities in Europe.

Only the Biontech/Pfizer vaccine, which is manufactured in Belgium and Germany, and Moderna, which manufactures in Spain and Switzerland, currently meet these requirements.

Comments

Comments are closed for this article.